DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Director Purchases $249,994.42 in Stock

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Director Gregory T. Lucier purchased 15,142 shares of the business’s stock in a transaction on Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the transaction, the director now directly owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

DENTSPLY SIRONA Stock Up 3.6 %

NASDAQ:XRAY opened at $16.15 on Thursday. DENTSPLY SIRONA Inc. has a twelve month low of $15.47 and a twelve month high of $34.28. The company has a market cap of $3.21 billion, a PE ratio of -7.80, a P/E/G ratio of 1.80 and a beta of 0.96. The company’s 50 day moving average is $18.71 and its two-hundred day moving average is $21.32. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be issued a $0.16 dividend. The ex-dividend date is Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 3.96%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -14.07%.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on XRAY shares. UBS Group reduced their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Robert W. Baird cut their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a report on Friday, February 28th. Jefferies Financial Group cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and lowered their price objective for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Evercore ISI restated an “in-line” rating and set a $20.00 price objective on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Finally, Morgan Stanley decreased their target price on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research report on Tuesday, December 17th. Eleven research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Hold” and an average target price of $23.58.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several hedge funds have recently added to or reduced their stakes in XRAY. Wealth Enhancement Advisory Services LLC raised its stake in shares of DENTSPLY SIRONA by 43.9% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 12,038 shares of the medical instruments supplier’s stock worth $326,000 after buying an additional 3,671 shares during the last quarter. State of Alaska Department of Revenue lifted its position in DENTSPLY SIRONA by 2.4% during the 3rd quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock worth $637,000 after acquiring an additional 560 shares in the last quarter. US Bancorp DE lifted its position in DENTSPLY SIRONA by 6.0% during the 3rd quarter. US Bancorp DE now owns 59,553 shares of the medical instruments supplier’s stock worth $1,612,000 after acquiring an additional 3,397 shares in the last quarter. Janney Montgomery Scott LLC raised its position in shares of DENTSPLY SIRONA by 45.4% in the 3rd quarter. Janney Montgomery Scott LLC now owns 43,203 shares of the medical instruments supplier’s stock valued at $1,169,000 after purchasing an additional 13,491 shares in the last quarter. Finally, Van ECK Associates Corp acquired a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at approximately $42,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.